2017 Distinguished Faculty

  • Mike Ando, Ph.D., Research Scientist, Google
  • Christophe Antczak, Ph.D., Senior Investigator, Hit Discovery Sciences, Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research
  • Peter Antinozzi, Ph.D., Assistant Professor, Department of Biochemistry, Department of Internal Medicine (Section of Molecular Medicine), Department of Genomics and Personalized Medicine Research, Center of Diabetes Research, Center on Diabetes, Obesity, and Metabolism, Wake Forest University School of Medicine
  • Kapil Bharti, Earl Stadtman Tenure-Track Investigator, Head Unit on Ocular and Stem Cell Translational Research, NIH, NEI
  • Beth Cimini, Ph.D., Computational Biologist, Broad Institute
  • Murat Cirit, Ph.D., Director, Systems Pharmacology, Massachusetts Institute of Technology
  • Mark Donowitz, M.D., LeBoff Professor of Medicine and Physiology, Johns Hopkins University School of Medicine and Director, Hopkins Center for Epithelial Disorders
  • Jonathan S. Dordick, Ph.D., Howard Isermann Professor of Chemical and Biological Engineering, Vice President for Research, Rensselaer Polytechnic Institute
  • Berton Earnshaw, Ph.D., Director, Data Science Research, Recursion Pharmaceuticals
  • Kristin Fabre, Ph.D., Microphysiological Systems Lead, Drug Safety & Metabolism, AstraZeneca
  • Rebecca Green, Ph.D., Research Scientist, Ludwig Institute for Cancer Research
  • Linda Griffith, Ph.D., Professor of Teaching Innovation, Biological Engineering, and Mechanical Engineering, Massachusetts Institute of Technology
  • James J. Hickman, Ph.D., Professor, Nanoscience Technology, Chemistry, Biomolecular Science, and Electrical Engineering, University of Central Florida
  • Jonathan Himmelfarb, M.D., Professor of Medicine; Director, Kidney Research Institute; Co-Director, Center for Dialysis Innovation, Joseph W. Eschbach MD Endowed Chair for Kidney Research, Department of Medicine, Division of Nephrology, University of Washington
  • Peter Horvath, Ph.D., Group Leader, Synthetic and Systems Biology Unit, Hungarian Academy of Sciences, BRC, Szeged; Finnish Distinguished Professor (FiDiPro) Fellow, Institute for Molecular Medicine Finland (FIMM)
  • Christopher C.W. Hughes, Ph.D., Professor & Francisco J. Ayala Chair, Department of Molecular Biology and Biochemistry; Professor, Biomedical Engineering; Director, Edwards Lifesciences Center for Advanced Cardiovascular Technology; UC Irvine
  • Dan Dongeun Huh, Wilf Family Term Assistant Professor, Bioengineering, University of Pennsylvania
  • Jonathan A. Lee, Ph.D., Senior Research Advisor, Quantitative Biology, Eli Lilly and Company
  • Sophie A. Lelièvre, D.V.M., Ph.D., LL.M. (public health), Professor, Department of Basic Medical Sciences, College of Veterinary Medicine; Associate Director, Collaborative Science, Purdue University Center for Cancer Research; Scientific Director, 3D Cell Culture Core (3D3C) Facility, Birck Nanotechnology Center, Discovery Park; Coleader, International Breast Cancer & Nutrition (IBCN); Professor of Cancer Pharmacology, West Lafayette-IU Medical School
  • Vance Lemmon, Ph.D., Walter G. Ross Distinguished Chair in Developmental Neuroscience, Professor of Neurological Surgery, The Miami Project to Cure Paralysis; Program Director in Computational Biology, Center for Computational Science, University of Miami Miller School of Medicine
  • Donald Lo, Ph.D., Associate Professor, Neurobiology, Duke University School of Medicine
  • Robert F. Murphy, Ph.D., Ray and Stephanie Lane Professor of Computational Biology and Professor of Biological Sciences, Biomedical Engineering, and Machine Learning; Head, Computational Biology Department, School of Computer Science, Carnegie Mellon University
  • William L. Murphy, Ph.D., Harvey D. Spangler Professor, Biomedical Engineering and Orthopedics; Co-Director, Stem Cell and Regenerative Medicine Center; Director, Human MAPs Center, University of Wisconsin
  • Mary-Ann Mycek, Ph.D., Associate Professor & Associate Chair, Biomedical Engineering; Faculty Member, Applied Physics Program; Core Member, Comprehensive Cancer Center, University of Michigan
  • Philip Nelson, Ph.D. Director, Software Engineering, Google
  • Ha Nam Nguyen, Ph.D., Co-founder and CEO, 3Dnamics
  • David Nolte, Ph.D., Professor, Physics, Purdue University; President, Animated Dynamics, Inc.
  • Ibrahim Tarik Ozbolat, Ph.D., Associate Professor, Engineering Science and Mechanics Department, Biomedical Engineering Department, The Huck Institutes of the Life Sciences, Materials Research Institute, Penn State University
  • Anne Plant, Ph.D., Chief of the Biosystems and Biomaterials Division, National Institute of Standards and Technology
  • Leo Price, Ph.D., CSO, OcellO
  • Stephen Reiling, Ph.D., Senior Scientist, Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Inc.
  • Gustavo Rohde, Ph.D., Associate Professor, Department of Biomedical Engineering, Department of Electrical and Computer Engineering, University of Virginia
  • Samuel Sances, Ph.D., Postdoctoral Researcher, Clive Svendsen Laboratory, Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center
  • Šeila Selimović, Ph.D., Tissue Chips Program Director, National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH
  • Michael L. Shuler, Ph.D., Samuel B. Eckert Professor, and J. & M. McCormick Chair, Chemical & Biomedical Engineering, Cornell University; Director of Cornell’s Nanobiotechnology Center
  • Thomas Shupe, Ph.D., Assistant Professor, Institute for Regenerative Medicine, Wake Forest Institute for Regenerative Medicine
  • Larry A. Sklar, Regents Professor of Pathology and Distinguished University Professor; Co-Leader Program in Cancer Therapeutics, UNM Comprehensive Cancer Center; Director, Drug Rescue, Repurposing, and Repositioning Network, UNM CTSC; Director, University of New Mexico Center for Molecular Discovery; Associate Director and Maralyn S. Budke/Robert E. Anderson Endowed Chair in Cancer Drug Discovery; PI, UNM Center of Excellence NCI Experimental Therapeutics Chemical Biology Consortium
  • Min Jae Song, Research Fellow, National Eye Institute, National Institute of Health
  • Jakub Swiercz, Head of In Vitro Pharmacology & Screening, iTeos Therapeutics SA
  • D. Lansing Taylor, Ph.D., Director, University of Pittsburgh Drug Discovery Institute & Allegheny Foundation Professor of Computational and Systems Biology, University of Pittsburgh
  • Fabien Vincent, Ph.D., Associate Research Fellow, Assay Development and Pharmacology, Hit Discovery and Lead Profiling, Pfizer Global Research & Development
  • Andreas Vogt, Ph.D., Associate Professor, Department of Computational and Systems Biology, University of Pittsburgh Drug Discovery Institute
  • Matt Wagoner, Associate Director, Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals